| 1 | Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. (Yao JC, Phan AT, Chang DZ, Wolff RA, Hess K, Gupta S, Jacobs C, Mares JE, Landgraf AN, Rashid A, Meric-Bernstam F) J Clin Oncol 2008 Sep 10;26(26):4311-8 555 Citations |
| 1 | Population-based study of islet cell carcinoma. (Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB) Ann Surg Oncol 2007 Dec;14(12):3492-500 278 Citations |
| 1 | Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. (Kouvaraki MA, Ajani JA, Hoff P, Wolff R, Evans DB, Lozano R, Yao JC) J Clin Oncol 2004 Dec 01;22(23):4762-71 521 Citations |
| 1 | Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. (Solorzano CC, Lee JE, Pisters PW, Vauthey JN, Ayers GD, Jean ME, Gagel RF, Ajani JA, Wolff RA, Evans DB) Surgery 2001 Dec;130(6):1078-85 225 Citations |
| 1 | Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. (Fuhrman GM, Charnsangavej C, Abbruzzese JL, Cleary KR, Martin RG, Fenoglio CJ, Evans DB) Am J Surg 1994 Jan;167(1):104-11; discussion 111-3 234 Citations |
| 1 | Nonfunctioning islet cell carcinoma of the pancreas. (Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani JA, Gagel RF, Sellin RV, Fenoglio CJ, Merrell RC, Hickey RC) Surgery 1993 Dec;114(6):1175-81; discussion 1181-2 104 Citations |
